WallStSmart
SNTI

Senti Biosciences Inc

NASDAQ: SNTI · HEALTHCARE · BIOTECHNOLOGY

$0.92
-5.99% today

Updated 2026-04-30

Market cap
$29.75M
P/E ratio
P/S ratio
1,352.38x
EPS (TTM)
$-2.73
Dividend yield
52W range
$1 – $4
Volume
0.2M

Senti Biosciences Inc (SNTI) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
1 of 8
Last 8 quarters
Avg EPS surprise
-47.8%
Last 4 quarters
Revenue YoY growth
-99.6%
Most recent quarter
EPS YoY growth
+20.9%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-13.6%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-14.8%
2025-11-13
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-27$-0.53-12.0%$0.88$0.77-12.4%
2025-11-13$-0.69-25.5%$1.89$1.61-14.8%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.47$-0.53-12.0%$22000.00-99.6%
2025-09-30$-0.55$-0.69-25.5%
2025-06-30$-0.55$-0.56-1.8%
2025-03-31$-0.56$-1.41-151.8%
2024-12-31$-3.13$-0.67+78.6%$5.86M+1658.6%
2024-09-30$-6.31
2024-06-30$-2.45
2024-03-31$-0.27$333000.00-74.1%
2023-12-31$-0.23$-0.42-82.2%$333000.00
2023-09-30$-0.44$0.24+154.5%$255000.00
2023-06-30$-0.48$-0.42+12.5%$937000.00
2023-03-31$-0.43$-0.42+2.3%$1.29M

Frequently asked questions

Has Senti Biosciences Inc beaten earnings estimates?
Senti Biosciences Inc has beaten Wall Street EPS estimates in 1 of its last 8 quarterly reports, with an average EPS surprise of -47.8% over the last 4 quarters.
How does SNTI stock react to earnings?
SNTI stock has moved an average of -13.6% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is Senti Biosciences Inc's revenue growth rate?
Senti Biosciences Inc reported year-over-year revenue growth of -99.6% in its most recent quarter, with EPS growing +20.9% year-over-year.